ArticleCancers2022

Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy.

Ahmad Algohary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.